Advanced search
1 file | 1.61 MB

The ION-Ghent guidelines for the management of immune related adverse events (irAE's)

Vibeke Kruse (UGent) , Max Schreuer (UGent) , Karim Vermaelen (UGent) , Piet Ost (UGent) , Tessa Kerre (UGent) , Barbara De Moerloose (UGent) and Lieve Brochez (UGent)
Author
Organization

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 1.61 MB

Citation

Please use this url to cite or link to this publication:

Chicago
Kruse, Vibeke, Max Schreuer, Karim Vermaelen, Piet Ost, Tessa Kerre, Barbara De Moerloose, and Lieve Brochez. 2017. “The ION-Ghent Guidelines for the Management of Immune Related Adverse Events (irAE’s).” Belgian Journal of Medical Oncology 11 (6): 265–275.
APA
Kruse, V., Schreuer, M., Vermaelen, K., Ost, P., Kerre, T., De Moerloose, B., & Brochez, L. (2017). The ION-Ghent guidelines for the management of immune related adverse events (irAE’s). BELGIAN JOURNAL OF MEDICAL ONCOLOGY, 11(6), 265–275.
Vancouver
1.
Kruse V, Schreuer M, Vermaelen K, Ost P, Kerre T, De Moerloose B, et al. The ION-Ghent guidelines for the management of immune related adverse events (irAE’s). BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 2017;11(6):265–75.
MLA
Kruse, Vibeke et al. “The ION-Ghent Guidelines for the Management of Immune Related Adverse Events (irAE’s).” BELGIAN JOURNAL OF MEDICAL ONCOLOGY 11.6 (2017): 265–275. Print.
@article{8554892,
  author       = {Kruse, Vibeke and Schreuer, Max and Vermaelen, Karim and Ost, Piet and Kerre, Tessa and De Moerloose, Barbara and Brochez, Lieve},
  issn         = {1784-7141},
  journal      = {BELGIAN JOURNAL OF MEDICAL ONCOLOGY},
  language     = {eng},
  number       = {6},
  pages        = {265--275},
  title        = {The ION-Ghent guidelines for the management of immune related adverse events (irAE's)},
  volume       = {11},
  year         = {2017},
}